Literature DB >> 1380154

Specificity of antisense oligonucleotides in vivo.

T M Woolf1, D A Melton, C G Jennings.   

Abstract

Antisense oligonucleotides are widely used as inhibitors of gene expression in cultured cells and have been proposed as potential therapeutic agents, but it is not known to what extent they are specific for their intended target RNAs. Statistical considerations indicate that if oligonucleotides can form hybrids with mRNA molecules in vivo by means of short or imperfect regions of complementarity, then the specificity of oligonucleotides as antisense reagents will be greatly compromised. We have used Xenopus oocytes as a model system in which to investigate the potential specificity of antisense oligonucleotides in vivo. We injected perfect and partially matched antisense oligonucleotides into oocytes and measured the resulting degradation of the target RNA in each case. On the basis of the extent to which antisense oligonucleotides can cause cleavage of RNAs at imperfectly matched target sites, we conclude that in this system it is probably not possible to obtain specific cleavage of an intended target RNA without also causing at least the partial destruction of many nontargeted RNAs.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1380154      PMCID: PMC49698          DOI: 10.1073/pnas.89.16.7305

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  23 in total

1.  Oct-3 is a maternal factor required for the first mouse embryonic division.

Authors:  M H Rosner; R J De Santo; H Arnheiter; L M Staudt
Journal:  Cell       Date:  1991-03-22       Impact factor: 41.582

2.  Retraction: Oct-3 is a maternal factor required for the first mouse embryonic division.

Authors:  M Rosner; R J De Santo; H Arnheiter; L M Staudt
Journal:  Cell       Date:  1992-05-29       Impact factor: 41.582

3.  Implications of ribozyme kinetics for targeting the cleavage of specific RNA molecules in vivo: more isn't always better.

Authors:  D Herschlag
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-15       Impact factor: 11.205

4.  Antisense inhibition of ras p21 expression that is sensitive to a point mutation.

Authors:  E H Chang; P S Miller; C Cushman; K Devadas; K F Pirollo; P O Ts'o; Z P Yu
Journal:  Biochemistry       Date:  1991-08-27       Impact factor: 3.162

5.  Rate of degradation of [alpha]- and [beta]-oligodeoxynucleotides in Xenopus oocytes. Implications for anti-messenger strategies.

Authors:  C Cazenave; M Chevrier; T T Nguyen; C Hélène
Journal:  Nucleic Acids Res       Date:  1987-12-23       Impact factor: 16.971

6.  Hybridization and dissociation rates of phosphodiester or modified oligodeoxynucleotides with RNA at near-physiological conditions.

Authors:  S Young; R W Wagner
Journal:  Nucleic Acids Res       Date:  1991-05-11       Impact factor: 16.971

7.  Quantitative hybridization-arrest of mRNA in Xenopus oocytes using single-stranded complementary DNA or oligonucleotide probes.

Authors:  E S Kawasaki
Journal:  Nucleic Acids Res       Date:  1985-07-11       Impact factor: 16.971

8.  Identification and characterization of alternatively spliced fibronectin mRNAs expressed in early Xenopus embryos.

Authors:  D W DeSimone; P A Norton; R O Hynes
Journal:  Dev Biol       Date:  1992-02       Impact factor: 3.582

9.  Nonspecific effects of oligodeoxynucleotide injection in Xenopus oocytes: a reevaluation of previous D7 mRNA ablation experiments.

Authors:  R C Smith; W M Bement; M A Dersch; E Dworkin-Rastl; M B Dworkin; D G Capco
Journal:  Development       Date:  1990-11       Impact factor: 6.868

10.  The maternal store of zinc finger protein encoding mRNAs in fully grown Xenopus oocytes is not required for early embryogenesis.

Authors:  T el-Baradi; T Bouwmeester; R Giltay; T Pieler
Journal:  EMBO J       Date:  1991-06       Impact factor: 11.598

View more
  51 in total

1.  Antisense oligonucleotides selected by hybridisation to scanning arrays are effective reagents in vivo.

Authors:  M Sohail; H Hochegger; A Klotzbücher; R L Guellec; T Hunt; E M Southern
Journal:  Nucleic Acids Res       Date:  2001-05-15       Impact factor: 16.971

2.  Guide RNA requirement for editing-site-specific endonucleolytic cleavage of preedited mRNA by mitochondrial ribonucleoprotein particles in Trypanosoma brucei.

Authors:  B K Adler; S L Hajduk
Journal:  Mol Cell Biol       Date:  1997-09       Impact factor: 4.272

3.  In vivo evidence that defects in the transcriptional elongation factors RPB2, TFIIS, and SPT5 enhance upstream poly(A) site utilization.

Authors:  Yajun Cui; Clyde L Denis
Journal:  Mol Cell Biol       Date:  2003-11       Impact factor: 4.272

4.  In vivo analysis of Kvbeta2 function in Xenopus embryonic myocytes.

Authors:  Meredith A Lazaroff; Alison D Taylor; Angeles B Ribera
Journal:  J Physiol       Date:  2002-06-15       Impact factor: 5.182

5.  Prioritized selection of oligodeoxyribonucleotide probes for efficient hybridization to RNA transcripts.

Authors:  Kevin J Luebke; Robert P Balog; Harold R Garner
Journal:  Nucleic Acids Res       Date:  2003-01-15       Impact factor: 16.971

6.  Hydrolysis of bulged nucleotides in hybrids formed by RNA and imidazole-derivatized oligo-2'-O-methylribonucleotides.

Authors:  Anthony D Saleh; Paul S Miller
Journal:  Nucleosides Nucleotides Nucleic Acids       Date:  2011-03       Impact factor: 1.381

7.  Inhibition of mesangial cell proliferation by E2F decoy oligodeoxynucleotide in vitro and in vivo.

Authors:  Y Maeshima; N Kashihara; T Yasuda; H Sugiyama; T Sekikawa; K Okamoto; K Kanao; Y Watanabe; Y S Kanwar; H Makino
Journal:  J Clin Invest       Date:  1998-06-01       Impact factor: 14.808

8.  Opening of the extraordinarily stable mini-hairpin d(GCGAAGC).

Authors:  B Jollès; M Réfrégiers; A Laigle
Journal:  Nucleic Acids Res       Date:  1997-11-15       Impact factor: 16.971

9.  RNase H-independent antisense activity of oligonucleotide N3 '--> P5 ' phosphoramidates.

Authors:  O Heidenreich; S Gryaznov; M Nerenberg
Journal:  Nucleic Acids Res       Date:  1997-02-15       Impact factor: 16.971

10.  Antisense treatment directed against mutated Ki-ras in human colorectal adenocarcinoma.

Authors:  H J Andreyev; P J Ross; D Cunningham; P A Clarke
Journal:  Gut       Date:  2001-02       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.